Factors Associated with Non-Adherence to Medication Among Geriatric Diabetic Patients in Mandeville, Jamaica
Abstract:
Diabetes
mellitus is a common health problem in Jamaica, causing a massive burden for
individuals, families, communities, and the health sector. Diabetes leads to
chronic physical and socioeconomic challenges. Adherence to diabetes therapy is
crucial for preventing complications and alleviating the socioeconomic burden
on the healthcare system. This study aimed to determine the factors
contributing to non-adherence to diabetic therapy among geriatric patients with
diabetes in Mandeville, Jamaica. Using a convenient sampling method, a
quantitative cross-sectional design was conducted across five health centers in
Mandeville, Jamaica. A sample size of 150 participants was surveyed using a
semi-structured, self-administered questionnaire. Using a convenient sampling
method, a quantitative cross-sectional design was conducted across five health
centers in Mandeville, Jamaica. A semi-structured, self-administered
questionnaire was used to survey 150 participants. The prevalence of diabetes
among geriatric diabetic patients was 62.5% for Type 2 diabetes and 37.5% for
Type 1 Diabetes. The sample size used indicates an overall prevalence of 100.
The study concluded that medication adherence was low and significantly
associated with poor compliance. However, future management interventions for
diabetic geriatrics should focus on improving medication adherence.
References:
[1]. Conget,
I., 2017, Medication adherence among ambulatory patients with type 2 diabetes:
in a tertiary healthcare setting in southwestern Nigeria. Pharmacy Practice,
PubMed.
[2]. World Health Organization, 2016, Factors
contributing to non-compliance among diabetics attending primary health centers
in the Al Hasa district of Saudi Arabia. Journal of Family Community
Medicine.
[3]. Lee, R.,
2010, A competing risks prescription refill model of compliance and persistence.
Value Health.
[4]. Cramer, J., 2004, Patient-reported
perceptions of side effects of antihyperglycemic medication and adherence to
medication regimens in persons with diabetes mellitus. Clinical Journal.
[5]. Pallock, R. J., 2011, Full coverage
for preventive medications after myocardial infarction. English Journal of Medicine.
[6]. Barron, T. I., Bennett, K., Feely,
J., 2010, A competing risks prescription refill model of compliance and persistence.
13(6),796–804.
[7]. Chao, J., Nau, D. P., and Aikens, J.
E., 2007, Patient-reported perceptions of side effects of antihyperglycemic
medication and adherence to medication regimens in persons with diabetes
mellitus. Clinical Journal, 29(1),177–80.
[8]. Choudhry, N. K., Avorn, J., Glynn, R.
J., 2011, Full coverage for preventive medications after myocardial infarction.
English Journal of Medicine, 365(22),2088–2097.
[9]. Ferguson, T., Tulloch-Reid, M., and
Wilks, R., 2010, The epidemiology of diabetes mellitus in Jamaica: a Caribbean:
a historical review. West Indian Medical Journal, (59),259- 64.
[10]. Haynes, R. B., Ackloo, E., Sahota,
N., McDonald, H. P., and Yao, X., 2008, Interventions for enhancing medication
adherence. Cochrane Database Systematic Review. [PubMed].
[11]. Hughes, C. M., 2004, Medication
non-adherence in the elderly: how big is the problem? Drugs Aging, (21),793–811.
[12]. Hutchins, V., Zhang, B., Flourence,
R. L., Krishnarajah, G., and Graham, J., 2011, A systematic review of
adherence, treatment satisfaction, and costs, in fixed-dose combination
regimens in type 2 diabetes,27(6),1157–68.
[13]. Jin. J., Sklar, G. E., MinSen, O. V.,
Chuen Li., 2008, Factors affecting therapeutic compliance: A review from the
patient’s perspective.4(1), 269–86.
[14]. Wild, S., Roglic, G., Green, A.,
Sicree, R., & King, H., 2004, Global Prevalence of Diabetes: Estimates for
the year 2000 and projections for 2030. Diabetes care, 27(5),
1047-1053.
[15]. Wilks, R., Younger, N., Tulloch-Reid,
M., McFarlane, S., Francis, D., 2008, Jamaica Health and Lifestyle Survey II.
[16]. Wong, M. C., Kong, A. P., So, W. Y.,
Jiang, J. Y., Chan, J. C., & Griffiths, S. M., 2011, Adherence to oral
hypoglycemic agents in 26 782 Chinese patients: a cohort study. The
Journal of Clinical Pharmacology, 51(10), 1474-1482.
[17]. Wong, E. S., Piette, J. D, Liu, C.,
2012, Measures of adherence to oral hypoglycemic agents at the primary care
clinic level. Med Care,50(7),591–598.
[18]. World Health Organization, 2003,
Adherence to Long-Term Therapies: Evidence for Action Geneva. Available from, http://whqlibdoc.who.int/publications/2003/9241545992.
Accessed January 29, 2013.
[19]. Bailer-Goering, M, M., Roy, k., Howards, D. H., 2019,
Relationship between adherence to Antidiabetic medication Regimen: and
out-of-pocket cost among people aged 35-64. with employer-sponsored health insurance,
16,180-381.
[20]. Barnett, K., Mercer, S., & Norbury, M., 2012, Epidemiology of Multi Morbidity and Implications for health care research: and medical education, 9836, 37-43.
